BioSpace News Archive

Daxor Corporation(NYSE American: DXR) (“Daxor” or the “Company”), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announced that it has closed its previously announced registered direct offering priced at-the-market of 140,352 shares of its common stock at a price of $14.25 per share, for aggregate gross proceeds of approximately $2.0 million.

Endologix, Inc., a developer and marketer of innovative treatments for aortic disorders, announced the grant of an inducement equity award to a newly hired employee.

A recent article published in “ACR Open Rheumatology” found that rheumatologist care was associated with better disease management for patients with advanced gout verses care from general practitioners.

TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it has priced its previously announced underwritten offering of units.

The Deputy Prime Minister will visit the Sunnybrook Health Sciences Centre to discuss coronavirus (COVID-19) management with front line staff. Closed to media. SOURCE Deputy Prime Minister’s Office

Sparta Science, the Silicon Valley company that applies data and technology in pursuit of human resilience, today announced a $16 million Series B funding round led by GSR Ventures U.S., a private investment firm primarily focused on early-stage companies in the United States developing AI-enabled healthcare technology, enterprise software, and consumer platforms.

BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the “Company” or “Bioasis”), today announced that it intends to redeem all of its outstanding 15% unsecured debentures issued November 8, 2019 (the “Debentures”) at a price equal to 110% of the principal amount of the Debentures (the “Redemption Price”).

InVivo Therapeutics Holdings Corp. (NVIV) today announced the pricing of a public offering of 2,545,455 shares of its common stock (or pre-funded warrants to purchase common stock in lieu thereof), together with warrants to purchase up to 2,545,455 shares of common stock at a combined effective price to the public of $2.75 per share (or pre-funded warrant) and associated warrant.

Unique public-private partnership aims to accelerate more than 15,000 STEM graduates and $2 billion in research to bring in up to 20,000 new jobs and $3 billion in annual economic impact

Bell invites members of the media to attend a major mental health announcement by Bell Let’s Talk and the Graham Boeckh Foundation.